Atlas Venture

Atlas Venture is an early-stage venture capital firm that creates and invests in biotechnology startup companies in the U.S. Atlas is headquartered in Cambridge, Massachusetts, where the majority of its investments are located.^[3] Atlas raised its fourteenth fund totaling $450 million in December 2024,^[4] and raised its Opportunity Fund II totaling $300 million in September 2021.^[5]

Atlas Venture

Company type	Private
Industry	Venture Capital
Founded	1980
Founder	Michiel de Haan[1]
Headquarters	Cambridge, Massachusetts, U.S.
Key people	Kevin Bitterman Bruce Booth Jean-Francois Formela Michael Gladstone David Grayzel Jason Rhodes[2]
Products	venture capital funds
AUM	$2.7 billion
Number of employees	29
Website	www.atlasventure.com

History

Originally formed in 1980 in Amsterdam as a subsidiary of NMB Bank, now part of ING Group, Atlas historically invested in both life sciences and information technology startup companies. In October 2014, Atlas announced its shift to a biotech-only venture capital firm, with the technology-focused investment team forming a new firm, Accomplice, to continue investing in information technology startups.^[6][7] Previously as a diversified firm, Atlas had raised over $3.0 billion of investor commitments across nine venture capital funds. The firm raised $705 million for its 2000-vintage fifth fund, $600 million for its 2001-vintage sixth fund, $385 million for its 2006-vintage seventh fund, $283 million for its 2009-vintage eighth fund, and $265 million for its 2013-vintage ninth fund.^[8][9] At its largest, the firm held European offices in London, Paris and Munich,^[10] and a West Coast office based in Seattle, Washington, in addition to the Boston-area headquarters. Today, the firm operates from a single office in Cambridge, Massachusetts.^[11][12]

In 2015 Atlas Venture raised its first biotech-dedicated fund, Fund X, at $280 million to invest in early stage biotech companies in the U.S. and around the world.^[13] In 2017 Atlas Venture raised Fund XI at $350 million. In January 2019 Atlas Venture raised $250 million for its Opportunity Fund I, a complementary strategy focusing investment in growth financings of companies in Atlas' main fund portfolios.^[14] In June 2020 Atlas Venture raised its Fund XII $400 million.^[15] In March 2022 Atlas Venture raised Fund XIII at $450 million. Atlas Venture raised Fund XIV in December 2024 at $450 million.